Anatomic Stage IIIA Breast Cancer AJCC v8 Active Not Recruiting Phase 0 Trials for Durvalumab (DB11714)

IndicationStatusPhase
DBCOND0109626 (Anatomic Stage IIIA Breast Cancer AJCC v8)Active Not Recruiting0
clinicaltrials.gov IdentifierTitlePurposeDrugs